Victim who contracted histoplasmosis after being administered Remicade is preparing a lawsuit against the manufacturer alleging that they failed to properly warn of the risk.
New York, NY (1888PressRelease) September 25, 2008 - Last week DrugSettlement.com, LLC, http://drugsettlement.com, reported that two of its member firms were investigating several claims involving deaths of patients who were administered TNF blockers, (Remicade, Enbrel, Humira and Cimzia), to treat rheumatoid arthritis. Actions are being prepared to be filed against the manufacturer is several venues.
One case involves a fifty year old woman form the Midwest who sought treatment for psoriasis from her dermatologist. The doctor prescribed a course of Remicade. After three treatments the woman began experiencing severe respiratory problems and returned to her doctor who sent her for testing. Her condition began to deteriorate quickly and she was admitted to the hospital.
While in the hospital the doctor's struggled to determine what was wrong, at one time wrongly suspecting that she was suffering from lung cancer. As her organ systems began to fail physicians at the hospital concluded that she was suffering from histoplasmosis.
Histoplasmosis is a fungal infection that is endemic to rural or farming areas. It is carried in the excrement of bats, It is most prevalent in states bordering the Ohio River valley and the lower Mississippi River. (Positive histoplasmin skin tests occur in as many as 80% of the people living in areas where H. capsulatum is common, such as the eastern and central United States.)
Unless an individual's immune system is suppressed the fungus remains asymptomatic. Patients administered TNF blockers like Remicade and Enbrel have suppressed immune systems as a result of therapy.
After a two month admission to the hospital, the patient still required two years of further treatment with powerful drugs that have left her in need of a liver transplant.
Two weeks ago the Food and Drug Administration ordered the manufacturers Remicade, Enbrel, Humira and Cimzia to include stronger black box warnings for their drugs. The FDA has ordered the manufacturers to warn users of the risk of developing potentially fatal fungal infections including histoplasmosis in a black box .
DrugSettlement.com will continue to provide information as it becomes available.
Our affiliated attorneys are currently investigating claims on behalf of victims and their families, for those who died or who suffered from fungal infections or cancer following the use of these medications. If you or a loved one has suffered an injury or any of the side effects listed above while taking these drugs, make sure to contact the experienced, and knowledgeable DrugSettlement.com lawyers at http://drugsettlement.com .